Sign in

CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company

Celcuity Inc.

Sign in to watch
Ticker
CELC
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
763-392-0767
Business address
16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
Former names
Celcuity LLC
  1. 4 Option exercise Director acquired 250 shares (option exercise)
  2. 4 Grant or award Director acquired 893 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Chief Science Officer acquired 20,000 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 80,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
  7. 4 Open-market sale Former 10% owner sold 3,100,000 shares at $102.50 ($317,750,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 1,530 shares (grant or award)
  11. 4 Grant or award Director acquired 1,530 shares (grant or award)
  12. 4 Grant or award Director acquired 1,530 shares (grant or award)
  13. 4 Grant or award Director acquired 1,530 shares (grant or award)
  14. 4 Grant or award Director acquired 1,530 shares (grant or award)
  15. 4 Grant or award Director acquired 1,530 shares (grant or award)
  16. 4 Option exercise Chief Science Officer acquired 1,000 shares (option exercise)
  17. 4 Gift Director gave 1,029 shares (gift)
  18. 4 Planned sale Director sold 25,000 shares at $140.68 ($3,517,000)
  19. 4 Planned sale Director sold 9,000 shares at an average $140.46 ($1,264,181)
  20. 4 Gift Director gave 10,000 shares (gift)

Page 1 of 10 · 187 filings